The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent‐4en and but‐3en analogues including MDMB‐4en‐PINACA

Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market

(2020) Caitlyn Norman et al.   Drug Testing and Analysis

In vitro activity profiling of Cumyl‐PEGACLONE variants at the CB 1 receptor: Fluorination versus isomer exploration

(2020) Liesl Janssens et al.   Drug Testing and Analysis

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex

(2019) Kaavya Krishna Kumar et al.   CELL

Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐ tert ‐leucine

(2019) Elise Wouters et al.   Drug Testing and Analysis

4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework

(2019) Alex J. Krotulski et al.   JOURNAL OF FORENSIC SCIENCES

Sample Mining and Data Mining: Combined Real‐Time and Retrospective Approaches for the Identification of Emerging Novel Psychoactive Substances

(2019) Alex J. Krotulski et al.   JOURNAL OF FORENSIC SCIENCES

Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection

(2019) Alex J Krotulski et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Pharmacological evaluation of new constituents of “Spice”: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds

(2018) Clara T. Schoeder et al.   Forensic Toxicology

Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors

(2018) Carolina Noble et al.   Drug Testing and Analysis

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review

(2017) Barry K. Logan et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

(2016) Samuel D. Banister et al.   ACS Chemical Neuroscience

Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay

(2016) Annelies Cannaert et al.   ANALYTICAL CHEMISTRY

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

(2015) Samuel D. Banister et al.   ACS Chemical Neuroscience

A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

(2015) Robert J. Tait et al.   CLINICAL TOXICOLOGY

Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice

(2015) A. Vigolo et al.   NEUROPHARMACOLOGY

Synthetic Cannabinoid Intoxication: A Case Series and Review

(2012) Carson R. Harris et al.   JOURNAL OF EMERGENCY MEDICINE

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

(2012) Kathryn A. Seely et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A brief history of ‘new psychoactive substances’

(2011) L. A. King et al.   Drug Testing and Analysis

Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products

(2010) Nahoko Uchiyama et al.   Forensic Toxicology